USD 21 Billion
Global Lung Cancer Market Size, Share, Growth Analysis, By Type(SCLC and NSCLC), By Application(Hospital and clinics, laboratories ad cancer research centers) - Industry Forecast 2024-2031
Report ID:
SQMIG35D2167 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
60 |
Figures:
75
Global Lung Cancer Market Insights
Lung Cancer Market size was valued at USD 21 Billion in 2021 and is poised to grow from USD 23.94 Billion in 2022 to USD 68.29 Billion by 2030, at a CAGR of 14% during the forecast period (2023-2030).
The global lung cancer market is a significant healthcare sector that encompasses the diagnosis, treatment, and management of lung cancer, a prevalent and life-threatening disease. Lung cancer remains a major public health challenge worldwide, with high mortality rates and a substantial economic burden. The market is driven by several factors, including the rising incidence of lung cancer, primarily due to smoking, exposure to environmental pollutants, and genetic predisposition. Advances in medical research and technology have led to the development of innovative diagnostic tools and treatment modalities, such as targeted therapies, immunotherapies, and precision medicine, offering new hope for patients. The market is witnessing a shift from traditional chemotherapy regimens to personalized and more effective treatment options, leading to improved patient outcomes. Furthermore, the increasing awareness about early detection and screening programs, along with the adoption of preventive measures, has contributed to the growth of the market. However, challenges remain, including the high cost of treatments, limited accessibility to healthcare facilities in certain regions, and the emergence of drug resistance. Nonetheless, the global lung cancer market continues to evolve rapidly, with ongoing research and development efforts focused on novel therapeutic approaches and the integration of artificial intelligence and big data analytics to enhance diagnosis, prognosis, and treatment decision-making. Overall, the market holds immense potential for growth and improvement in patient care, with a strong emphasis on personalized medicine and multidisciplinary collaborations to combat this devastating disease.
US Lung Cancer Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
NSCLC
Fastest Growth
NSCLC
Growth Rate
14% CAGR
Global Lung Cancer Market ($ Bn)
Country Share for North America Region (%)
Global Lung Cancer Market By Type ($ Bn)
Global Lung Cancer Market By Type (%)
To get more reports on the above market click here to Buy The Report
Global Lung Cancer Market Segmental Analysis
The Global Lung Cancer Market is segmented on the basis of type, application, and region. Based on type, the market can be segmented into SCLC and NSCLC. Based on application, the market is segmented into Hospital and clinics, laboratories ad cancer research centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Lung Cancer Market Analysis By Type
The dominant segment in the global lung cancer market is non-small cell lung cancer (NSCLC). NSCLC accounts for the majority of lung cancer cases and comprises several subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. This dominance can be attributed to the higher incidence rates of NSCLC compared to small cell lung cancer (SCLC) and the availability of a broader range of treatment options specific to NSCLC, such as targeted therapies and immunotherapies. The focus on personalized medicine and advancements in molecular profiling techniques have further strengthened the position of NSCLC as the dominant segment in the market.
On the other hand, the fastest-growing segment in the global lung cancer market is small cell lung cancer (SCLC). While NSCLC remains the dominant segment, SCLC has witnessed significant advancements in recent years, including the development of novel therapies and treatment approaches. The introduction of immune checkpoint inhibitors and combination therapies has shown promising results in the treatment of SCLC, leading to increased research and investment in this segment. Additionally, the identification of genetic mutations and biomarkers specific to SCLC has fueled the development of targeted therapies, further contributing to its rapid growth in the market. The increasing focus on improving outcomes for SCLC patients and the development of more effective treatment options have positioned it as the fastest-growing segment in the lung cancer market.
Lung Cancer Market Analysis By Application
The dominant segment in the global lung cancer market based on application is hospitals and clinics. These healthcare facilities play a crucial role in the diagnosis, treatment, and management of lung cancer. Hospitals and clinics are the primary points of care for patients seeking medical attention for lung cancer-related symptoms. These facilities offer a comprehensive range of services, including imaging tests, biopsies, surgeries, chemotherapy, radiation therapy, and supportive care. They provide a multidisciplinary approach to lung cancer treatment, involving oncologists, pulmonologists, radiologists, surgeons, and other healthcare professionals. The dominance of hospitals and clinics can be attributed to their accessibility, infrastructure, and expertise in providing comprehensive care to lung cancer patients.
The fastest-growing segment in the global lung cancer market based on application is cancer research centers and laboratories. These institutions are dedicated to advancing scientific knowledge, developing new therapies, and conducting clinical trials for lung cancer. Cancer research centers and laboratories are at the forefront of innovation and discovery, focusing on molecular profiling, genomic sequencing, and biomarker identification to tailor treatment options for individual patients. With the increasing emphasis on precision medicine and targeted therapies, the demand for research and development in lung cancer has grown significantly. These centers and laboratories collaborate with pharmaceutical companies, academic institutions, and healthcare organizations to accelerate the development of novel treatments and improve patient outcomes. The rapid growth of cancer research centers and laboratories is driven by the need for advancements in understanding lung cancer biology, identifying new therapeutic targets, and facilitating the translation of scientific discoveries into clinical practice.
Global Lung Cancer Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Lung Cancer Market Regional Insights
The dominant segment in the global lung cancer market based on region is North America. North America has a strong healthcare infrastructure, advanced medical technologies, and a high level of awareness regarding lung cancer. The region also exhibits a higher prevalence of risk factors such as smoking and environmental pollution. North America is home to numerous leading pharmaceutical companies, research institutions, and academic centers that contribute to the development of innovative treatments and therapies for lung cancer. Additionally, the region has well-established healthcare reimbursement systems, which facilitate access to lung cancer diagnostics and treatments, making it the dominant segment in the market.
The fastest-growing segment in the global lung cancer market based on region is Asia Pacific. Asia Pacific has witnessed a substantial rise in the incidence of lung cancer in recent years, primarily due to factors like increasing tobacco consumption, air pollution, and changing lifestyles. The region is experiencing a rapid expansion in healthcare infrastructure, improving access to diagnostic facilities and treatment options. Additionally, rising investments in research and development activities, growing awareness about early detection, and the adoption of advanced therapies contribute to the fast growth of the lung cancer market in Asia Pacific. The region's large population and the presence of emerging economies also offer significant market potential and opportunities for growth in the coming years.
Global Lung Cancer Market By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Lung Cancer Market Dynamics
Lung Cancer Market Drivers
Continuous advancements in medical research and technology
- One key driver of the global lung cancer market is the continuous advancements in medical research and technology. The ongoing progress in understanding the biology of lung cancer, as well as the development of innovative diagnostic tools, targeted therapies, immunotherapies, and precision medicine, are driving the market forward. These advancements provide new treatment options, improved patient outcomes, and enhanced capabilities for early detection and personalized treatment approaches.
Lung Cancer Market Restraints
High cost of lung cancer treatments
- A key restraint of the market is the high cost of lung cancer treatments. The cost of lung cancer therapies, including targeted therapies and immunotherapies, can be substantial, placing a financial burden on patients and healthcare systems. The high cost may limit access to these advanced treatments, particularly in regions with limited healthcare resources or inadequate insurance coverage. The affordability and accessibility of lung cancer treatments pose a significant challenge, hindering the market's potential for broader adoption and equitable patient care.
Request Free Customization of this report to help us to meet your business objectives.
Global Lung Cancer Market Competitive Landscape
The competitive landscape of the global lung cancer market is characterized by intense competition and a diverse range of players, including pharmaceutical companies, medical device manufacturers, research institutions, and healthcare providers. The market is driven by continuous research and development efforts aimed at introducing innovative therapies, diagnostic tools, and treatment approaches. Strategic collaborations, partnerships, and mergers and acquisitions are common strategies adopted by players to enhance their product portfolios, expand their geographic presence, and gain a competitive edge. Additionally, the market is influenced by factors such as pricing strategies, regulatory compliance, reimbursement policies, and the ability to address unmet needs in patient care. The dynamic nature of the competitive landscape underscores the ongoing pursuit of advancements in lung cancer diagnosis, treatment, and patient outcomes.
Lung Cancer Market Top Player’s Company Profile
- Sanofi S.A. (France)
- Pfizer Inc. (US)
- GlaxoSmithKline (UK)
- F. Hoffmann-La Roche AG (Switzerland)
- Boehringer Ingelheim GmbH (Germany)
- Novartis International AG (Switzerland)
- Bristol Myers Squibb (US)
- Johnson & Johnson (US)
- Takeda Pharmaceutical Company Limited (Japan)
- AbbVie Inc. (US)
- Celgene Corporation (US)
- Amgen Inc. (US)
- Astellas Pharma Inc. (Japan)
- Daiichi Sankyo Company, Limited (Japan)
- Eisai Co., Ltd. (Japan)
- Ipsen (France)
- Kyowa Kirin Co., Ltd. (Japan)
Lung Cancer Market Recent Developments
- In May 2021 Roche announced that the drug "Tecentriq" demonstrated steady improvement in patients with early-stage lung cancer. After a median follow-up of 32.2 months, data from 1,005 randomized Stage II-IIIA NSCLC patients showed a 21% reduction in the risk of cancer recurrence or death. The safety profile of Tecentriq in this trial remained consistent with previous findings, with no new safety concerns identified. Adverse events were reported in 92.7% of the entire randomized group compared to 70.7% of those receiving best supportive care.
- In April 2021, AstraZeneca plc announced the approval of the drug "Tagrisso" in China for the early treatment of lung cancer. China's National Medical Products Administration (NMPA) granted Tagrisso a license as an adjuvant treatment for early-stage lung cancer patients with an EGFR mutation. Tagrisso has now received approvals for the treatment of early-stage lung cancer in over a dozen countries, including the US.
Global Lung Cancer Key Market Trends
- Growing emphasis on precision medicine and targeted therapies: One key market trend in the global lung cancer market is the growing emphasis on precision medicine and targeted therapies. With advancements in understanding the molecular characteristics of lung cancer, there has been a shift towards personalized treatment approaches that target specific genetic mutations or biomarkers. This trend is driven by the desire to improve treatment outcomes, minimize adverse effects, and provide tailored therapies based on individual patient profiles. The development of targeted therapies and the integration of molecular profiling techniques have paved the way for more precise and effective treatments, leading to improved patient care and prognosis in the field of lung cancer.
Global Lung Cancer Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Lung Cancer Market analysis, the global lung cancer market is a dynamic and competitive sector driven by factors such as the rising incidence of lung cancer, advancements in medical research and technology, and a growing emphasis on personalized medicine. Non-small cell lung cancer (NSCLC) is the dominant segment, benefiting from a higher prevalence and a broader range of treatment options. Small cell lung cancer (SCLC) is the fastest-growing segment, fueled by advancements in therapies and targeted approaches. Hospitals and clinics are the dominant application segment, providing comprehensive care to lung cancer patients. Cancer research centers and laboratories are the fastest-growing application segment, driving innovation and translating scientific discoveries into clinical practice. North America leads as the dominant region, while Asia Pacific is the fastest-growing region. Key drivers include advancements in medical research, while the high cost of treatments poses a restraint. The market is characterized by intense competition, strategic collaborations, and ongoing research and development efforts to enhance patient care. Key trends include the focus on precision medicine and targeted therapies, offering personalized treatment options for improved outcomes in lung cancer patients.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 21 Billion |
| Market size value in 2031 | USD 68.29 Billion |
| Growth Rate | 14% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Lung Cancer Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Lung Cancer Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Lung Cancer Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Lung Cancer Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Lung Cancer Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Lung Cancer Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Lung Cancer Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
